Skip to Main content Skip to Navigation
Journal articles

Synthesis and biological evaluation of (3,4,5-trimethoxyphenyl)indol-3-ylmethane derivatives as potential antivascular agents.

Abstract : Combretastatin A-4 (CSA-4), a stilbene derivative, is a potent vascular disrupting agent (VDA) with the structural requirement of a cis-configuration to maintain a molecular geometry and a correct orientation of both phenyl groups. A series of indolic analogues of CSA-4 was synthesized by means of an efficient strategy. Six compounds (20b, 25b-27b, 32b, and 35b) were identified as potent inhibitors of tubulin polymerization and also displayed cytotoxic activities on B16 melanoma cells at a nanomolar level. Both activities were well correlated with the ability to induce morphological changes of EA.hy 926 endothelial cells. In conclusion, the cis-stilbene skeleton of CSA-4 could conveniently be replaced by the 3-aroylindolic moiety, thus avoiding any isomerization leading to inactive trans compounds.
Document type :
Journal articles
Complete list of metadatas
Contributor : Pharmacologie Chimique Et Génétique <>
Submitted on : Friday, November 30, 2007 - 4:29:04 PM
Last modification on : Tuesday, September 22, 2020 - 3:37:41 AM



Grégory Dupeyre, Guy Chabot, Sylvianne Thoret, Xavier Cachet, Johanne Seguin, et al.. Synthesis and biological evaluation of (3,4,5-trimethoxyphenyl)indol-3-ylmethane derivatives as potential antivascular agents.. Bioorganic and Medicinal Chemistry, Elsevier, 2006, 14 (13), pp.4410-26. ⟨10.1016/j.bmc.2006.02.037⟩. ⟨inserm-00193139⟩



Record views